Search research articles
Contact Us
Filters
Showing results (61-70 of 111) with videos related to
Page
of 12
Sort By:
Expert Opinion on Biological Therapy
|
December 10, 2020
<i>HLA-Cw6</i> and other HLA-C alleles, as well as <i>MICB-DT, DDX58,</i> and <i>TYK2</i> genetic variants associate with optimal response to anti-IL-17A treatment in patients with psoriasis
Martina Morelli, Marco Galluzzo, Stefania Madonna, et al.
Expert Opinion on Biological Therapy
|
April 1, 2026
Tildrakizumab in the treatment of moderate-to-severe plaque psoriasis: expert insights from Italian real-world experience
Angelo Ruggiero, Martina Burlando, Anna Balato, et al.
Expert Opinion on Biological Therapy
|
October 5, 2021
Tildrakizumab for treatment of moderate to severe psoriasis: an expert opinion of efficacy, safety, and use in special populations
Marco Galluzzo, Andrea Chiricozzi, Elisa Cinotti, et al.
Cell Cycle (Georgetown, Tex.)
|
August 17, 2019
Skin immunity and its dysregulation in psoriasis
Caterina Lanna, Mara Mancini, Roberta Gaziano, et al.
Pharmaceuticals (Basel, Switzerland)
|
April 28, 2023
A Real-Life Study on the Use of Tildrakizumab in Psoriatic Patients
Elena Campione, Sara Lambiase, Ruslana Gaeta Shumak, et al.
The Journal of Dermatological Treatment
|
February 23, 2026
Toward the definition of moderate psoriasis: an expert opinion
Antonio Costanzo, Federico Bardazzi, Martina Burlando, et al.
Italian Journal of Dermatology and Venereology
|
May 23, 2024
Anti-Herpes zoster vaccination in patients with dermatologic diseases: a position statement from the Italian SIDeMaST group of sexually transmitted, infectious and tropical diseases
Giulia Ciccarese, Francesco Drago, Astrid Herzum, et al.
Clinical Rheumatology
|
January 6, 2018
Effectiveness and safety of ustekinumab in naïve or TNF-inhibitors failure psoriatic arthritis patients: a 24-month prospective multicentric study
Maria Sole Chimenti, Augusta Ortolan, Mariagrazia Lorenzin, et al.
The Journal of Dermatology
|
April 3, 2020
Real life experience of apremilast in psoriasis and arthritis psoriatic patients: Preliminary results on metabolic biomarkers
Sara Mazzilli, Caterina Lanna, Carlo Chiaramonte, et al.
Melanoma Research
|
July 17, 2025
Peripheral blood inflammation indexes correlate with advanced stages in cutaneous melanoma: a single-center retrospective study
Cosimo Di Raimondo, Angela Fico, Mariagrazia Cicala, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 111) with videos related to
Sort By:
Page
of 12
Expert Opinion on Biological Therapy
|
December 10, 2020
<i>HLA-Cw6</i> and other HLA-C alleles, as well as <i>MICB-DT, DDX58,</i> and <i>TYK2</i> genetic variants associate with optimal response to anti-IL-17A treatment in patients with psoriasis
Martina Morelli, Marco Galluzzo, Stefania Madonna, et al.
Expert Opinion on Biological Therapy
|
April 1, 2026
Tildrakizumab in the treatment of moderate-to-severe plaque psoriasis: expert insights from Italian real-world experience
Angelo Ruggiero, Martina Burlando, Anna Balato, et al.
Expert Opinion on Biological Therapy
|
October 5, 2021
Tildrakizumab for treatment of moderate to severe psoriasis: an expert opinion of efficacy, safety, and use in special populations
Marco Galluzzo, Andrea Chiricozzi, Elisa Cinotti, et al.
Cell Cycle (Georgetown, Tex.)
|
August 17, 2019
Skin immunity and its dysregulation in psoriasis
Caterina Lanna, Mara Mancini, Roberta Gaziano, et al.
Pharmaceuticals (Basel, Switzerland)
|
April 28, 2023
A Real-Life Study on the Use of Tildrakizumab in Psoriatic Patients
Elena Campione, Sara Lambiase, Ruslana Gaeta Shumak, et al.
The Journal of Dermatological Treatment
|
February 23, 2026
Toward the definition of moderate psoriasis: an expert opinion
Antonio Costanzo, Federico Bardazzi, Martina Burlando, et al.
Italian Journal of Dermatology and Venereology
|
May 23, 2024
Anti-Herpes zoster vaccination in patients with dermatologic diseases: a position statement from the Italian SIDeMaST group of sexually transmitted, infectious and tropical diseases
Giulia Ciccarese, Francesco Drago, Astrid Herzum, et al.
Clinical Rheumatology
|
January 6, 2018
Effectiveness and safety of ustekinumab in naïve or TNF-inhibitors failure psoriatic arthritis patients: a 24-month prospective multicentric study
Maria Sole Chimenti, Augusta Ortolan, Mariagrazia Lorenzin, et al.
The Journal of Dermatology
|
April 3, 2020
Real life experience of apremilast in psoriasis and arthritis psoriatic patients: Preliminary results on metabolic biomarkers
Sara Mazzilli, Caterina Lanna, Carlo Chiaramonte, et al.
Melanoma Research
|
July 17, 2025
Peripheral blood inflammation indexes correlate with advanced stages in cutaneous melanoma: a single-center retrospective study
Cosimo Di Raimondo, Angela Fico, Mariagrazia Cicala, et al.
Page
of 12